Vertex Pharmaceuticals Inc. buy Subdi
Start price
26.01.18
/
50%
€150.98
Target price
06.02.18
€178.60
Performance (%)
-8.89%
End price
06.02.18
€137.56
Summary
This prediction ended on 06.02.18 with a price of €137.56. With a performance of -8.89%, the BUY prediction by Subdi finished with a loss. Subdi has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Vertex Pharmaceuticals Inc. | 1.093% | 1.093% | 33.870% | 140.506% |
| iShares Core DAX® | -0.448% | 2.344% | 15.948% | 18.098% |
| iShares Nasdaq 100 | 0.834% | 5.019% | 30.983% | 56.534% |
| iShares Nikkei 225® | -0.479% | 0.550% | 9.206% | 5.013% |
| iShares S&P 500 | -0.352% | 2.631% | 26.224% | 46.697% |
Comments by Subdi for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Subdi stimmt der Buy-Einschätzung von tamam zu
Subdi stimmt am 26.01.2018 der Buy-Einschätzung von tamam mit dem Kursziel 170$ zu.
Überschrift: tamam stimmt der Outperform-Einschätzung der institutionellen Analysten zu
(Vom Mitglied beendet)